We provide access to high-quality research use only (RUO) cellular source material for cell and gene therapy R&D and process development.
Cellular Source Material for Research Use
We provide access to high-quality research use only (RUO) cellular source material for cell and gene therapy R&D and process development.
Cellular source material that scales beyond R&D
In research and process development phases, the central concern should be determining the critical quality attributes of source materials and the resulting therapy — not questioning whether results have been impacted by low-quality cellular source material.
NMDP BioTherapies℠ is a partner for high-quality source material that can grow and scale seamlessly as a therapy advances from R&D to process development, clinical trials and beyond.
Available RUO cellular source material products and services
We work with our partners to supply fresh or cryopreserved cellular source material along with other products and services including:
- Leukopaks
- Whole blood
- Isolated cells (i.e. PBMCs)
- Testing services
- Cord Blood Units
Partnering from the start for long-term value
Our team helps to navigate the ways cellular source material decisions today can affect clinical and commercial scalability into the future.
As therapies transition to the clinic, our GMP-compliant source material supports engineering runs and clinical manufacturing. This allows developers to design engineering runs using the same processes that will be used for clinical trials.
We work with partners to understand their companies’ needs and challenges, and support their therapy development every step of the way.
Explore NMDP solutions
Simplify CBU sourcing: access cord blood units to match a variety of required characteristics for cell therapy development, all through a central point of access.